ATP Research

ATP (Apple Tree Partners) is a leading life sciences venture capital firm that specializes in creating and building transformative biotechnology companies from the ground up. Founded in 1999, the firm employs a unique 'venture studio' model, where it identifies high-impact scientific innovations and provides the necessary capital, strategic leadership, and operational support to develop them into independent entities. ATP's portfolio spans a wide range of therapeutic areas, including oncology, immunology, neurology, and rare diseases, utilizing diverse modalities such as small molecules, biologics, and advanced cell and gene therapies. The firm is known for its long-term commitment to its companies, often serving as the sole or lead investor through multiple stages of development. By bridging the gap between academic research and commercial drug development, ATP continues to drive the next generation of medical breakthroughs.